XML 128 R116.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total compensation expense $ 8,667 $ 7,508 $ 3,975
Income tax benefits 2,832 2,458 1,143
Performance Shares      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total compensation expense 7,207 $ 5,318 2,320
Expense $ 5,179    
Weighted average period (years) 1 year 3 months 18 days    
Status of, and changes in, the Performance Share Unit Plan units granted to employees      
Outstanding at the beginning of the period (in shares) 598,911    
Granted (in shares) 290,895    
Forfeited (in shares) (77,957)    
Exercised (in shares) (130,339)    
Outstanding at the end of the period (in shares) 681,510 598,911  
Vested and expected to vest (in shares) 681,510    
Great West Lifeco Inc | Employee and Directors Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Total compensation expense $ 1,460 $ 2,190 $ 1,655
Expense $ 1,673    
Weighted average period (years) 1 year 7 months 6 days    
Shares under option      
Outstanding at the beginning of the period (in shares) 4,062,001    
Granted (in shares) 434,300    
Exercised (in shares) (655,384)    
Cancelled and Expired (in shares) (393,942)    
Outstanding at the end of the period (in shares) 3,446,975 4,062,001  
Vested and expected to vest at the end of the period (in shares) 3,446,975    
Exercisable at the end of the period (in shares) 2,190,591    
Exercise price (Whole dollars)      
Outstanding at the beginning of the period (in dollars per share) $ 23.25    
Granted (in dollars per share) 29.26    
Exercised (in dollars per share) 24.58    
Cancelled and Expired (in dollars per share) 28.35    
Outstanding at the end of the period (in dollars per share) 24.88 $ 23.25  
Vested and expected to vest at the end of the period (in dollars per share) 24.88    
Exercisable at the end of the period (in dollars per share) $ 23.22    
Remaining contractual term      
Outstanding, December 31, 2017 6 years 3 months 18 days    
Vested and expected to vest, December 31, 2017 6 years 3 months 18 days    
Exercisable, December 31, 2017 5 years 3 months 18 days    
Aggregate intrinsic value      
Outstanding, December 31, 2017 [1] $ 11,012    
Vested and expected to vest, December 31, 2017 [1] 11,012    
Exercisable, December 31, 2017 [1] $ 10,327    
Other information      
Weighted average fair value of options granted (in dollars per share) $ 2.75 $ 2.74 $ 3.33
Intrinsic value of options exercised [2] $ 2,869 $ 2,102 $ 4,234
Fair value of options vested $ 2,203 $ 1,605 $ 1,670
Weighted-average assumptions      
Dividend yield 3.98% 3.99% 3.66%
Expected volatility 13.99% 19.03% 19.10%
Risk free interest rate 1.25% 0.80% 0.90%
Expected duration (years) 6 years 6 years 6 years
[1] The aggregate intrinsic value is calculated as the difference between the market price of Lifeco common shares on December 31, 2017, and the exercise price of the option (only if the result is positive) multiplied by the number of options.
[2] The intrinsic value of options exercised is calculated as the difference between the market price of Lifeco common shares on the date of exercise and the exercise price of the option multiplied by the number of options exercised.